Time: 20:33

Turnbull government unveils…

The Turnbull government has unveiled its National Science Statement. The statement, which focuses on the long-term importance of science to the economy and wider society, articulates government’s vision and objectives for Australian science. It also sets principles for government policy-making in science. The…

Read More...
Turnbull government unveils National Science Statement
The Turnbull government has unveiled its National Science Statement. The statement, which focuses on the long-term importance…

Join the survey…

The Australian life sciences industry is invited to assist in the 2017 National Capability Audit for the Medical Countermeasures (MCM) Initiative, to survey and understand Australia’s capability and capacity to support research and development for MCM products. Examples of medical…

Read More...
Join the survey of Australian medical countermeasures
The Australian life sciences industry is invited to assist in the 2017 National Capability Audit…

Sinodinos: We have…

Investment in innovation and collaboration between researchers, industry and government is essential, according to minister for industry, innovation and science, Senator Arthur Sinodinos AO. During an address to the National Press Club in Canberra yesterday, Sinodinos challenged criticism of the Turnbull government’s…

Read More...
Sinodinos: We have to get better at…
Investment in innovation and collaboration between researchers, industry and government is essential, according to minister for…

Latest News

23 March 2017Latest News

Turnbull government unveils National Science Statement

The Turnbull government has unveiled its National Science Statement. The statement, which focuses on the long-term importance of science to the economy…

23 March 2017AusBiotech

Join the survey of Australian medical countermeasures

The Australian life sciences industry is invited to assist in…

23 March 2017Latest News

Sinodinos: We have to get better at…

Investment in innovation and collaboration between researchers, industry and government is…

23 March 2017Company News

Neuren reports top-line results from Phase 2 trial

Neuren Pharmaceuticals (ASX:NEU) has reported top-line results for its Phase 2 clinical trial in girls with Rett syndrome aged 5 to…

23 March 2017Latest News

EnGeneIC doses first patient in Phase 1…

EnGeneIC has begun dosing patients in a US-based open-label Phase…

21 March 2017Company News

Clarity establishes European subsidiary

Clarity Pharmaceuticals, which specialises in medical imaging, has officially established…

21 March 2017Latest News

TGA seeks feedback on support needs for…

The TGA is investigating ways that it might provide support…

21 March 2017Company News

Opthea meets with European regulators

Opthea (ASX:OPT), a developer of novel biologic therapies for the treatment of eye diseases, says it has concluded positive European…

21 March 2017Latest News

TGA reforms one step closer

Legislation giving effect to government’s response to the review of…